The path to long-term weight management: challenges and solutions
GLP-1s changed the pharmacology; adherence, tolerability and lifestyle context now decide long-term outcomes. Where evidence generation has to catch up.
Insight · · 1 min
The arrival of GLP-1 receptor agonists reshaped the pharmacology of weight management, but the outcome question is unchanged: what actually happens over years, not months, once the prescription meets a life. Adherence, tolerability, dietary and behavioural context, and payer dynamics all bend the effect curve. Evidence generation has to catch up, with continuous real-world capture, adherence-aware analyses, and endpoints that reflect metabolic and functional health rather than weight in isolation. The next generation of weight-management studies will look less like a 12-month trial and more like a long-lived programme that treats time as a first-class variable.
Written by the Evidilya scientific team. For interviews, references or a full publication list, use the contact page.
Talk to our team.
Bring us the evidence question you're wrestling with, we'll tell you the shortest defensible path.